Iran J Basic Med Sci. 2015 Apr;18(4):370-9.

Protective effect of royal jelly in 2,4,6 trinitrobenzene sulfonic acid-induced colitis in rats.

Iranian journal of basic medical sciences

Turan Karaca, Yesim Hulya Uz, Selim Demirtas, Ihsan Karaboga, Guray Can

PMID: 26019800 PMCID: PMC4439452

Abstract

OBJECTIVES: In the present study, we evaluated immunological and immunomodulatory properties of royal jelly (RJ) in 2,4,6 trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats.

MATERIALS AND METHODS: Eighteen adult female Wistar albino rats were divided into three groups of six animals each: a control group that received only saline solution, a TNBS-induced colitis group, and a TNBS-colitis+RJ group that received 250 mg/kg/day of RJ for seven days before the induction of colitis, following by the same treatment for an additional seven days. At the end of the experiment, cardiac blood and colon samples were obtained under deep anaesthesia from the animals in all groups. Serum interleukin-1β (IL-1β), tumour necrosis factor-alpha (TNF-α) and IL-10 levels were analyzed with an enzyme-linked immunosorbent assay (ELISA). Five-micrometre-thick sections were stained with haematoxylin-eosin (H&E) for microscopic evaluations. For immunohistochemical evaluations, the paraffin sections were stained with anti-CD3 (cluster of differentiation), anti-CD5, anti-CD8 and anti-CD45.

RESULTS: The results showed that the oral RJ treatment inhibited proinflammatory cytokines, IL-1β and TNF-α secretion, while increasing anti-inflammatory cytokine IL-10 production in the TNBS-induced colitis+RJ group compared with the colitis group not treated with RJ. The colitis was not as severe in the colitis+RJ group, with ulcerative damage, weight loss and inflammatory scores suggesting that impaired CD3-, CD5-, CD8- and CD45-positive T cell immune responses likely mediated the anti-inflammatory effect.

CONCLUSION: The antioxidant and anti-inflammatory properties of RJ protected colon mucosa against TNBS-induced colitis in rats orally treated with RJ.

Keywords: Colitis; Rats; Royal jelly; TNBS

References

1. J Agric Food Chem. 2006 Oct 18;54(21):8328-34 - PubMed
2. Free Radic Res. 2005 Sep;39(9):1017-25 - PubMed
3. Allergol Immunopathol (Madr). 2012 Nov-Dec;40(6):357-61 - PubMed
4. Int Immunopharmacol. 2007 Sep;7(9):1211-20 - PubMed
5. J Food Sci. 2008 Nov;73(9):R117-24 - PubMed
6. Immunopharmacol Immunotoxicol. 2007;29(3-4):521-36 - PubMed
7. Shock. 2005 Jun;23(6):556-64 - PubMed
8. Biosci Biotechnol Biochem. 2004 Jan;68(1):138-45 - PubMed
9. Am J Physiol. 1994 Apr;266(4 Pt 1):G560-7 - PubMed
10. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Oct;38(10):1020-8 - PubMed
11. Neurochem Res. 2010 Jun;35(6):940-6 - PubMed
12. Res Pharm Sci. 2013 Jan;8(1):1-8 - PubMed
13. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Mar;30(3):278-80, 283 - PubMed
14. Iran J Med Sci. 2013 Jun;38(2 Suppl):140-9 - PubMed
15. Jpn J Pharmacol. 1990 Jul;53(3):331-7 - PubMed
16. Int Immunopharmacol. 2001 Mar;1(3):521-32 - PubMed
17. Life Sci. 2003 Sep 5;73(16):2029-45 - PubMed
18. Eur J Histochem. 2010 Oct 21;54(4):e35 - PubMed
19. Gastroenterology. 2007 Jun;132(7):2359-70 - PubMed
20. Iran Red Crescent Med J. 2011 Dec;13(12):884-90 - PubMed
21. J Med Food. 2009 Oct;12 (5):1170-2 - PubMed
22. World J Gastroenterol. 2014 Feb 28;20(8):2051-61 - PubMed
23. J Mol Histol. 2009 Aug;40(4):317-24 - PubMed
24. Middle East J Dig Dis. 2012 Jan;4(1):40-7 - PubMed
25. Chem Biol Interact. 2014 Feb 25;209:48-55 - PubMed
26. Curr Pharm Des. 2014;20(7):1082-96 - PubMed
27. Dig Surg. 2002;19(4):306-11; discussion 311-2 - PubMed
28. J Med Food. 2006 Fall;9(3):363-7 - PubMed
29. Eur J Pharmacol. 2008 Jan 28;579(1-3):411-7 - PubMed
30. Phytother Res. 2008 Nov;22(11):1511-9 - PubMed
31. Clin Exp Immunol. 1999 May;116(2):238-45 - PubMed
32. J Physiol Pharmacol. 2013 Oct;64(5):587-95 - PubMed
33. World J Gastroenterol. 2007 Apr 21;13(15):2166-73 - PubMed
34. J Physiol Pharmacol. 2012 Dec;63(6):631-40 - PubMed

Publication Types

• Journal Article